Michael Baldwin

Michael Baldwin

Boehringer Ingelheim - / United States
Economics & Econometrics / Economics
AD Scientific Index ID: 4387397
person_outline Michael Baldwin's MOST POPULAR ARTICLES
1-) The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UKG Brusselle, D Price, K Gruffydd-Jones, M Miravitlles, DL Keininger, ...International journal of chronic obstructive pulmonary disease 10, 2207, 20151722015
2-) Comparative efficacy of long-acting bronchodilators for COPD-a network meta-analysisS Cope, JF Donohue, JP Jansen, M Kraemer, G Capkun-Niggli, ...Respiratory research 14 (1), 1-18, 2013942013
3-) Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysisM Schlueter, N Gonzalez-Rojas, M Baldwin, L Groenke, F Voss, T ReasonTherapeutic advances in respiratory disease 10 (2), 89-104, 2016612016
4-) Patient-reported outcomes, patient-reported information: from randomized controlled trials to the social web and beyondM Baldwin, A Spong, L Doward, A GnanasakthyThe Patient: Patient-Centered Outcomes Research 4, 11-17, 2011612011
5-) Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observationalDLKDP Kevin Gruffydd-Jones , Guy Brusselle , Rupert Jones , Marc Miravitlles ...Primary care respiratory Medicine 26, 16002, 201638*2016